MTT: Benchmark Tetrazolium Salt for In Vitro Cell Viability Assays

Executive Summary: MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) is a tetrazolium salt widely adopted for in vitro cell viability and metabolic activity assays, especially in cancer and apoptosis research (Lv et al., 2020). The compound is reduced primarily by mitochondrial NADH-dependent oxidoreductases to yield insoluble purple formazan, enabling robust, quantitative, and colorimetric detection of viable cells. APExBIO supplies high-purity MTT (≥98%) as SKU B7777, which outperforms generic reagents in reproducibility across diverse cell models (see benchmark review). MTT is soluble at ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, and ≥2.5 mg/mL in water with ultrasonic assistance. Proper storage at -20°C is recommended to prevent degradation and maintain assay integrity (APExBIO product page).

Biological Rationale

Cell viability and proliferation are critical metrics in biomedical research, particularly for cancer, neurobiology, and pharmacology. Colorimetric viability assays enable high-throughput, quantitative assessment of cell health. Tetrazolium salts such as MTT provide a direct readout of cellular metabolic activity, reflecting both mitochondrial function and general cell health (Benchmark review). The reduction of MTT occurs only in metabolically active cells, distinguishing viable from nonviable populations. This specificity underpins its widespread use as a cytotoxicity, proliferation, or drug screening reagent.

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT is a membrane-permeable, cationic tetrazolium salt. Upon entering live cells, it is reduced by mitochondrial NADH-dependent oxidoreductases and, to a lesser extent, by extra-mitochondrial enzymes. The reduction yields insoluble formazan crystals, which accumulate intracellularly. The amount of formazan formed is directly proportional to the number of metabolically active cells (Lv et al., 2020). After incubation, the formazan is solubilized (typically in DMSO), and absorbance is measured at 570 nm. This colorimetric output provides a quantitative index of cell viability or proliferation. The reaction does not require external mediators or cofactors, simplifying workflow and minimizing background.

Evidence & Benchmarks

• MTT-based assays reliably quantify cell viability and proliferation in human umbilical vein endothelial cells (HUVECs) under variable experimental conditions (see Table I).
• MTT reduction correlates with mitochondrial metabolic activity and is blocked by mitochondrial poisons, confirming specificity (Lv et al., 2020).
• APExBIO’s MTT (SKU B7777) demonstrates ≥98% purity, supporting reproducibility and sensitivity in cancer, apoptosis, and drug screening assays (Product page).
• MTT is compatible with direct solubilization in DMSO, ethanol, or water (with ultrasonic assistance), enabling flexible protocols (APExBIO).
• MTT-based viability assessment underpins angiogenesis studies and pharmacological screening in translational research (Lv et al., 2020).

This article extends the mechanistic and practical context provided in 'MTT and the Future of Translational Cell Viability' by focusing on quantitative benchmarks and reagent solubility parameters for SKU B7777.

Applications, Limits & Misconceptions

MTT is widely employed in:

• Drug screening for cytotoxicity, proliferation, and apoptosis in cancer research.
• Metabolic activity measurement in stem cells, neurons, and primary cultures.
• Assaying mitochondrial enzyme activity and oxidative stress responses.
• Quantifying proliferative and anti-proliferative effects in pharmacological and toxicological studies.

For a practical perspective on troubleshooting and workflow optimization, see 'Solving Lab Challenges with MTT'; this article further clarifies boundaries of assay sensitivity and reagent handling.

Common Pitfalls or Misconceptions

• MTT only measures metabolic activity, not direct cell count; it cannot distinguish quiescent but viable cells from metabolically inactive ones.
• Formazan solubilization must be complete for accurate quantification; incomplete dissolution leads to underestimation of viability.
• NADH-independent reduction (e.g., by some non-mitochondrial enzymes) is minimal but can contribute to background signal; controls are essential.
• MTT is not suitable for non-adherent cell types unless adapted protocols are used to prevent loss of formazan crystals during washes.
• Prolonged storage of MTT solutions at room temperature leads to degradation and reduced assay sensitivity.

Workflow Integration & Parameters

MTT (APExBIO SKU B7777) is supplied at ≥98% purity and is intended for research use only. Stock solutions can be prepared at concentrations of ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, or ≥2.5 mg/mL in water with ultrasonic assistance. For typical 96-well plate assays, add MTT solution (final 0.5 mg/mL) to cells and incubate 1–4 hours at 37°C. After incubation, solubilize formazan in DMSO and measure absorbance at 570 nm. MTT powder should be stored at -20°C; avoid long-term storage of stock solutions. For more granular optimization and scenario-driven troubleshooting, see 'MTT: High-Purity Tetrazolium Salt for Cell Viability Assays', which this article updates with new quantitative solubility and workflow data.

Conclusion & Outlook

MTT remains the benchmark tetrazolium salt for in vitro cell viability and metabolic activity assays. Its well-characterized mechanism, high sensitivity, and compatibility with standard lab formats make it integral to cancer biology, apoptosis research, and drug screening. APExBIO’s high-purity MTT (SKU B7777) offers robust performance and lot-to-lot consistency, supporting reproducibility in translational and basic research. Future developments may integrate MTT-based readouts with multiplexed assay platforms for broader phenotypic profiling. For detailed product specifications or to order, see the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) product page.